EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open‐label feasibility study

Olena Said iD, Ece Sengun Filiz iD, Dominic Stringer, Briana Applewhite, Vanessa Kellermann, Hiba Mutwalli, Sevgi Bektas, Melahat Nur Akkese, Ashish Kumar, Ben Carter, Mima Simic, Dilveer Sually und 10 weitere

European Eating Disorders Review · 2024

DOI: 10.1002/erv.3060 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift European Eating Disorders Review, 2024. Verfasst von Olena Said und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Hauptthemen laut MEDLINE: Anorexia Nervosa. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre Health Technology Assessment Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antipsychotics are routinely prescribed off‐label for anorexia nervosa (AN) despite limited evidence. This article presents a protocol of a study aiming to assess the feasibility of a future definitive trial on olanzapine in young people with AN. Methods and analysis In an open‐label, one‐armed feasibility study, 55 patients with AN or atypical AN, aged 12–24, receiving outpatient, inpatient or day‐care treatment who are considered for olanzapine treatment will be recruited from NHS sites based in England. Assessments will be conducted at screening, baseline and at 8‐, 16 weeks, 6‐ and 12 months. Primary feasibility parameters will be proportions of patients who agree to take olanzapine and who adhere to treatment and complete study assessments. Qualitative methods will be used to explore acceptability of the intervention and study design. Secondary feasibility parameters will be changes in body mass index, psychopathology, side effects, health‐related quality of life, carer burden and proportion of participants who would enrol in a future randomised controlled trial. The study is funded by the National Institute for Health Research via Health Technology Assessment programme.

Discussion

Olanzapine for young PEople with aNorexia nervosa will inform a future randomised controlled trial on the efficacy and safety of prescribing olanzapine in young people with AN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anorexia NervosaHumansAdolescentOlanzapineFeasibility StudiesQuality of LifeSurveys and QuestionnairesRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

anorexia nervosafeasibilityolanzapineweight restoration

Substanzen

Olanzapine

Autor:innen und Institutionen

  • Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Department of Health Service and Population Research, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Department of Clinical Nutrition, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Mersey Care NHS Foundation Trust, Merseyside, UK.

ORCID-Profile: Olena Said, Ece Sengun Filiz, Janet Treasure, Hubertus Himmerich

Förderung

  • National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre Health Technology Assessment Programme

Zitieren

APA

Said, O., Sengun Filiz, E., Stringer, D., Applewhite, B., Kellermann, V., Mutwalli, H., Bektas, S., Akkese, M. N., Kumar, A., Carter, B., Simic, M., Sually, D., Bentley, J., Young, A. H., Madden, S., Byford, S., Landau, S., Lawrence, V., Treasure, J., …, & Himmerich, H. (2024). Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open‐label feasibility study. European Eating Disorders Review. https://doi.org/10.1002/erv.3060

Vancouver

Said O, Sengun Filiz E, Stringer D, Applewhite B, Kellermann V, Mutwalli H, et al. Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open‐label feasibility study. European Eating Disorders Review. 2024. doi:10.1002/erv.3060

BibTeX
@article{Said2024,
  author = {Said, Olena and Sengun Filiz, Ece and Stringer, Dominic and Applewhite, Briana and Kellermann, Vanessa and Mutwalli, Hiba and Bektas, Sevgi and Akkese, Melahat Nur and Kumar, Ashish and Carter, Ben and Simic, Mima and Sually, Dilveer and Bentley, Jessica and Young, Allan H and Madden, Sloane and Byford, Sarah and Landau, Sabine and Lawrence, Vanessa and Treasure, Janet and Schmidt, Ulrike and Nicholls, Dasha and Himmerich, Hubertus},
  title = {Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open‐label feasibility study},
  journal = {European Eating Disorders Review},
  year = {2024},
  doi = {10.1002/erv.3060}
}
Kostenlos starten →